Showing results (361-370 of 519) with videos related to

Sort By:
Pageof 52
The Journal of Trauma and Acute Care Surgery|April 20, 2017
A multiyear assessment of a hospital-school program to promote teen motor vehicle safetyPurnima Unni, Cristina M Estrada, Dai H Chung, et al.
Scientific Reports|December 16, 2016
Simultaneous observation of free and defect-bound excitons in CH3NH3PbI3 using four-wave mixing spectroscopySamuel A March, Charlotte Clegg, Drew B Riley, et al.
BMC Veterinary Research|August 21, 2015
A rapid field test for the measurement of bovine serum immunoglobulin G using attenuated total reflectance infrared spectroscopyIbrahim Elsohaby, Siyuan Hou, J Trenton McClure, et al.
Substance Use & Misuse|September 24, 2016
Validating a Hazardous Drinking Index in a Sample of Sexual Minority Women: Reliability, Validity, and Predictive AccuracyBarth B Riley, Tonda L Hughes, Sharon C Wilsnack, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 27, 2021
RSTNCOVID Burns: A multi-centre service evaluation and stakeholder survey of the impact of COVID-19 on burns care in England, Wales and Northern IrelandGeorgina S A Phillips, Justin C R Wormald, Ryo Yoshimura, et al.
Anaesthesia|April 16, 2021
Validation of the factors influencing family consent for organ donation in the UKR M K Curtis, A R Manara, S Madden, et al.
Leukemia Research|November 16, 2004
Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or olderChadi Nabhan, Lynn M Rundhaugen, Mary B Riley, et al.
The Journal of Surgical Research|July 1, 1990
In vitro alterations in human fibroblast behavior secondary to silicone polymersR L McCauley, W B Riley, R A Juliano, et al.
Annals of Surgical Oncology|November 21, 1997
Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreasR C Montgomery, J P Hoffman, L B Riley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive diseaseC Nabhan, L Rundhaugen, M Jatoi, et al.
Pageof 52